Lymphatica Medtech
Developer of implantable devices designed to re-establish lymphatic circulation in individuals affected by lymphedema. The company produces the first active implantable lymphatic bypass, consisting of...
Valuation
$36.4M
Market implied
Share Price
N/A
Total Raised
$37M
Last Round
N/A